46P - Evolution of overall survival (OS) in patients (pts) with incident NSCLC in Denmark and Sweden: A SCAN-LEAF study analysis from the I-O Optimise initiative
Authors
- J. Sørensen (Copenhagen, Denmark)
- S. Ekman (Stockholm, Sweden)
- O. Brustugun (Oslo, Norway)
- P. Horvat (London, United Kingdom)
- D. Patel (London, United Kingdom)
- M. Rosenlund (Stockholm, Sweden)
- A. Mette Kejs (Copenhagen, Denmark)
- A. Juarez-Garcia (Uxbridge, United Kingdom)
- M. Daumont (Braine-L'Alleud, Belgium)
- L. Lacoin (Ladeuze, Belgium)
- J. Penrod (Princeton, NJ, United States of America)
- J. O'Donnell (Princeton, NJ, United States of America)
- M. Planck (Lund, Sweden)
Speakers
- J. Sørensen (Copenhagen, Denmark)
47P - Treatment (Tx) patterns and overall survival (OS) in patients (pts) with NSCLC in Sweden: A SCAN-LEAF study analysis from the I-O Optimise initiative
Authors
- S. Ekman (Stockholm, Sweden)
- J. Sørensen (Copenhagen, Denmark)
- O. Brustugun (Oslo, Norway)
- P. Horvat (London, United Kingdom)
- D. Patel (London, United Kingdom)
- M. Rosenlund (Stockholm, Sweden)
- A. Mette Kejs (Copenhagen, Denmark)
- A. Juarez-Garcia (Uxbridge, United Kingdom)
- M. Daumont (Braine-L'Alleud, Belgium)
- L. Lacoin (Ladeuze, Belgium)
- J. Penrod (Princeton, NJ, United States of America)
- J. O'Donnell (Princeton, NJ, United States of America)
- M. Planck (Lund, Sweden)
Speakers
- S. Ekman (Stockholm, Sweden)
48P - Education and lung cancer: A Mendelian randomisation study
Authors
- H. Zhou (Guangzhou, China)
- Y. Zhang (Guangzhou, China)
- J. Liu (Guangzhou, China)
- Y. Yang (Guangzhou, China)
- W. Fang (Guangzhou, China)
- S. Hong (Guangzhou, China)
- G. Chen (Guangzhou, China)
- S. Zhao (Guangzhou, China)
- Z. Zhang (Guangzhou, China)
- J. Shen (Guangzhou, China)
- W. Xian (Guangzhou, China)
- Y. Huang (Guangzhou, China)
- H. Zhao (Guangzhou, China)
- L. Zhang (Guangzhou, China)
Speakers
- H. Zhou (Guangzhou, China)
49P - A Mendelian randomization study of the effects of Crohn’s disease on lung cancer
Authors
- J. Liu (Guangzhou, China)
- H. Zhou (Guangzhou, China)
- Y. Zhang (Guangzhou, China)
- W. Fang (Guangzhou, China)
- Y. Yang (Guangzhou, China)
- S. Hong (Guangzhou, China)
- G. Chen (Guangzhou, China)
- S. Zhao (Guangzhou, China)
- J. Shen (Guangzhou, China)
- W. Xian (Guangzhou, China)
- Y. Huang (Guangzhou, China)
- H. Zhao (Guangzhou, China)
- L. Zhang (Guangzhou, China)
Speakers
- J. Liu (Guangzhou, China)
52P - Concordance, decision impact, and satisfaction for a computerized clinical decision support system in treatment of lung cancer patients
Authors
- K. Lee (Jupiter, United States of America)
- W. Felix (Boston, MA, United States of America)
- G. Jackson (Nashville, TN, United States of America)
Speakers
- K. Lee (Jupiter, United States of America)
53P - Pulmonary tuberculosis: A hurdle to overcome for early lung cancer diagnosis in TB burden countries
Authors
- M. Akter (Dhaka, Bangladesh)
- S. Ahmed (Dhaka, Bangladesh)
Speakers
- M. Akter (Dhaka, Bangladesh)
57P - Non-small cell lung carcinoma (NSCLC) patients with baseline brain imaging: A prospective observational study
Authors
- G. NARESH (NEW DELHI, India)
- P. Malik (New Delhi, India)
- S. Khurana (New Delhi, India)
- S. Pathy (New Delhi, India)
- M. Yadav (New Delhi, India)
- D. Jain (New Delhi, India)
- H. Kancharla (New Delhi, India)
Speakers
- G. NARESH (NEW DELHI, India)
58P - Evaluation of a care path for patients with lung tumors and co-existing interstitial lung disease
Authors
- M. Ronden-Kianoush (Amsterdam, Netherlands)
- E. Nossent (Amsterdam, Netherlands)
- C. Dickhoff (Amsterdam, Netherlands)
- S. Nijman (Amsterdam, Netherlands)
- I. Bahce (Amsterdam, Netherlands)
- S. Senan (Amsterdam, Netherlands)
- F. Spoelstra (Amsterdam, Netherlands)
Speakers
- M. Ronden-Kianoush (Amsterdam, Netherlands)
59P - Comparison of internal target volume delineation using CT datasets of four-dimensional computed tomography in lung cancer radiotherapy
Authors
- S. BUSHRA (Mumbai, India)
- A. Tibdewal (Mumbai, India)
- N. Mummudi (Mumbai, India)
- R. Kinhikar (Mumbai, India)
- Y. Ghadi (Mumbai, India)
- J. Agarwal (Mumbai, India)
Speakers
- S. BUSHRA (Mumbai, India)
60P - Nomogram for patients with stage I small cell lung cancer: A competing risk analysis
Authors
- J. Liu (Guangzhou, China)
- H. Zhou (Guangzhou, China)
- Y. Zhang (Guangzhou, China)
- W. Fang (Guangzhou, China)
- Y. Yang (Guangzhou, China)
- S. Hong (Guangzhou, China)
- G. Chen (Guangzhou, China)
- S. Zhao (Guangzhou, China)
- X. Chen (Guangzhou, China)
- Z. Zhang (Guangzhou, China)
- W. Xian (Guangzhou, China)
- J. Shen (Guangzhou, China)
- Y. Huang (Guangzhou, China)
- H. Zhao (Guangzhou, China)
- L. Zhang (Guangzhou, China)
Speakers
- J. Liu (Guangzhou, China)
61P - Value of post-radiotherapy for limited stage small cell lung cancer on basis of a prognostic scoring model
Authors
- J. Yu (Wuhan, China)
- W. Ouyang (Wuhan, China)
- J. Hu (Wuhan, China)
- J. Zhang (Wuhan, China)
- C. Xie (Wuhan, China)
Speakers
- J. Yu (Wuhan, China)
62P - External validation of a survival score for limited stage small cell lung cancer treated with chemoradiotherapy
Authors
- L. Käsmann (Munich, Germany)
- R. Abdo (München, Germany)
- J. Taugner (München, Germany)
- C. Eze (Munich, Germany)
- M. Dantes (Munich, Germany)
- O. Roengvoraphoj (Munich, Germany)
- C. Belka (Munich, Germany)
- F. Manapov (Munich, Germany)
Speakers
- L. Käsmann (Munich, Germany)